Updated for the July 1, 2026 Bridge
Does Medicare Cover Ozempic in 2026?
For type 2 diabetes, yes — Part D has covered Ozempic for years. For weight loss, no, and the new $50 programme does not change that. Medicare started covering GLP-1s for weight management on July 1, 2026, which has produced a lot of headlines. Ozempic is not on the list.
The two routes are also mutually exclusive by design, in a way that surprises people. We archived Medicare's coverage rules on July 25, 2026; everything below quotes them.
- Part D covers Ozempic on its type 2 diabetes indication, subject to your plan's formulary and tier.
- The new $50 GLP-1 Bridge covers Foundayo, Wegovy and Zepbound KwikPen — not Ozempic.
- Having type 2 diabetes disqualifies you from the Bridge, so you cannot use both routes.
- Ozempic for weight loss without diabetes is covered by neither route.
- In that gap? Compare cash-pay prices before paying retail. How we make money.
Does Medicare cover Ozempic?
It depends entirely on why it is prescribed. Ozempic is FDA-approved for type 2 diabetes, and Part D plans cover it on that indication under their normal formulary rules — the drug is on most plans, usually with prior authorization or step therapy, at whatever tier your plan assigns. Prescribed for weight loss, it falls under the long-standing statutory bar on Part D paying for weight-loss drugs.
What changed in July 2026 is that Medicare carved out an exception to that bar. The exception has a fixed drug list, and Ozempic is not on it.
The one list that decides it
Three drugs, and Ozempic is not among them. This is not an oversight. Ozempic's FDA approval is for type 2 diabetes, not chronic weight management, so it sits outside a programme built specifically for weight management. Its sibling drug Wegovy is the same molecule — semaglutide — approved for weight loss, and Wegovy is on the list, in both injection and tablet form. Our Medicare and Wegovy guide covers that route in full.
Part D and diabetes: the route that does work
If you have type 2 diabetes, Ozempic is a normal Part D drug and the questions are ordinary ones: is it on your plan's formulary, what tier, does it need prior authorization, is there a step-therapy requirement ahead of it. Those answers vary by plan and change each January, so the only reliable source is your own plan's current drug list.
Worth knowing: this route counts toward your Part D deductible and out-of-pocket cap in the normal way, which the $50 Bridge does not. For someone with high total drug spend, the ordinary Part D route can be the better economics even at a higher monthly copay.
The catch-22 for weight loss
Here is the part almost nobody has written about, because the programme is only weeks old. The Bridge explicitly excludes people who have type 2 diabetes.
Put the two rules together and the logic closes:
| Your situation | Ozempic | Why |
|---|---|---|
| Type 2 diabetes | Covered under Part D | On-label indication; formulary and tier rules apply |
| Type 2 diabetes, wanting the $50 rate | No | Diabetes disqualifies you from the Bridge, and Ozempic is not on its list anyway |
| Weight loss, no diabetes | No | Off-label for weight management; the Bridge covers Wegovy, not Ozempic |
| Weight loss, no diabetes, willing to switch drug | Wegovy at $50 | Same molecule, on the Bridge list, if you meet a BMI tier |
That last row is the useful one. If your goal is semaglutide rather than the Ozempic brand specifically, the conversation to have with your prescriber is about Wegovy, not about appealing an Ozempic denial.
Is there a workaround to get Ozempic for weight loss?
Not through Medicare, and you should be sceptical of anyone who says otherwise. A prescriber cannot re-label an off-label use into coverage, and a diabetes diagnosis you do not have is fraud, not a workaround. The three legitimate paths are narrower and worth knowing precisely.
Switch molecule form. Wegovy is semaglutide, the same active ingredient, approved for weight management and on the Bridge list at $50 if you meet a BMI tier. This is the realistic route for most people asking this question.
Check whether another indication genuinely applies. Cardiovascular risk reduction in established cardiovascular disease is a separate, coverable use of semaglutide. This has to be clinically true, not manufactured.
Pay cash. The manufacturer savings cards for these drugs exclude Medicare, Medicaid and TRICARE by their own terms, so the $25-a-month figure that circulates online is not available to you. Cash-pay telehealth is, and the prices are not what the advertisements suggest.
What it costs when neither route opens
Ozempic's list price without coverage runs well over a thousand dollars a month, and essentially nobody should pay it. The realistic comparison for a Medicare enrollee who cannot use either route is between cash-pay semaglutide programmes, where the variable that decides your total is almost never the advertised headline — it is the membership fee stacked on top of the medication.
Our cost calculator adds those fees back in, and the provider matcher ranks what is left against your budget and answers.
How to check in one call
- If you have type 2 diabetes: ask your Part D plan whether Ozempic is on the 2026 formulary, at what tier, and whether prior authorization or step therapy applies. That is the whole question.
- If you want it for weight loss: do not ask about Ozempic. Ask whether you meet a GLP-1 Bridge BMI tier, and whether Wegovy is the right drug for you.
- If you have diabetes and want the $50 rate: you cannot have both. Work out which is cheaper for your total year, since the Bridge copay does not count toward your out-of-pocket cap.
FAQ
Will Medicare pay for Ozempic for weight loss in 2026?
No. The July 2026 GLP-1 Bridge covers Foundayo, Wegovy and Zepbound KwikPen only, and the statutory bar on Part D covering weight-loss drugs otherwise still applies to Ozempic.
How do people on Medicare pay for Ozempic?
Through Part D on the type 2 diabetes indication, at their plan's tier copay. Without diabetes, the practical options are switching to Wegovy under the Bridge or paying cash.
Can I get Ozempic for $25 a month on Medicare?
No. The manufacturer savings offers that produce figures like that require commercial insurance and exclude Medicare, Medicaid and TRICARE by their own terms.
Is Wegovy the same as Ozempic?
Both are semaglutide. They differ in approved indication and dosing, which is exactly why one is on the Bridge list and the other is not. Which is appropriate for you is a question for your clinician.
Does Medicare Advantage cover Ozempic?
Medicare Advantage plans with drug coverage follow the same Part D rules, so the diabetes indication is covered subject to that plan's formulary, and the weight-loss bar applies equally.
Sources and update history
Primary documents, archived July 25, 2026: Medicare.gov — Weight loss drugs coverage; Medicare publication 12234, "GLP-1 Drugs for $50 a Month" (June 20, 2026). The Bridge is a temporary programme and its drug list can change — verify before acting. Companion pages: Medicare and Wegovy, Medicare and Zepbound.